Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies - Additional Information (Details)

v3.23.1
Commitments and Contingencies - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Commitments and Contingencies [Line Items]    
Monthly fee included in minimum lease payment $ 480  
Research and development expense $ 12,435 $ 9,170
Wuxi Agreement | WuXi Advanced Therapies    
Commitments and Contingencies [Line Items]    
Lease expiration period 2024-01  
Early termination fee $ 1,500  
Research Service Agreement | Children's Hospital of Philadelphia    
Commitments and Contingencies [Line Items]    
Research and development expense 0 $ 166
Liability related to agreement $ 480